about
Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs.Suppression of cortical spreading depression in migraine prophylaxisDrug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs.Region specific distribution of levomepromazine in the human brain.Postmortem Quetiapine Reference Concentrations in Brain and Blood.Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophreniaInhibition of ATP-sensitive potassium channels by haloperidol.Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficitsProtracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in ratsAntipsychotic drugs alter neuronal development including ALM neuroblast migration and PLM axonal outgrowth in Caenorhabditis elegans.Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue.In vitro prediction of brain penetration - a case for free thinking?Haloperidol, but not olanzapine, may affect expression of PER1 and CRY1 genes in human glioblastoma cell lineImpact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture.Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.Genome-wide association study of lymphoblast cell viability after clozapine exposure.Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells.Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation.Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro.Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells.Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor.Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat.Disturbed circadian motor activity patterns in postcardiotomy delirium.Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: implications for the dopaminergic neurotoxicity of HPP+.mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor.Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.The antidepressant fluoxetine mobilizes vesicles to the recycling pool of rat hippocampal synapses during high activity.A comparative study of the plasma membrane permeabilization and fluidization induced by antipsychotic drugs in the rat brain.Toward an improved prediction of human in vivo brain penetration.Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients.Antipsychotic Induced Alteration of Growth and Proteome of Rat Neural Stem CellsActions of psychotropic drugs beyond their primary targets at the synaptic cleft
P2860
Q27693888-872225C2-F3D2-40E0-8A75-677968EBFDFAQ28294907-E6FF0C14-C6F7-4287-832A-E3093913DA19Q33260941-BEDF6300-5342-4CDA-95A6-6FA1422E7736Q34431345-2107A7BE-C19E-4FE5-BB07-7198299B149FQ34484290-FC3A46FE-36D0-434E-B191-13DD5B010B58Q34540452-F307A285-4A4E-4464-A96E-4276CD2DC552Q34660862-50451D7D-7D69-413C-AAB9-8C409BFA6CA0Q35048471-44B7163A-AEFD-4945-ABF8-0F9D15156A33Q35376749-E0C8FA85-4425-4119-BD81-91B1BA299DE0Q36383589-73B56B78-6A3B-43D0-9E28-82C1C358FC83Q37011467-37E4650F-DDE4-4814-B2A4-BA541747D560Q37230404-B47254C8-D1BE-4BA1-9093-54E8D0EA8738Q38090652-A2DD6218-8CA7-46AA-8EC2-5337A84F41C7Q38740890-3E436C4F-698A-4FC0-9DAE-4EA5EF896829Q38842712-B3FB4C1A-DFAB-4650-932F-1EA2B332496EQ38927030-5859A3AD-3EF6-4100-85C2-C230DF72E1D5Q38967700-FF1F105D-5E39-455A-A0B8-C64A3570128CQ38969289-21247EB4-E9BC-4CD0-86FA-AB0DD913233FQ39849166-7D597FDD-C28E-4D56-838C-58F9CFE14574Q39851823-96398BF5-CE63-4BB8-9E28-5C815309D9E2Q40078303-BBE4FE1D-7592-4AEB-8F15-204A6BBA26A7Q40577984-8684AC3D-0366-4673-8027-5FA0B75B8BA1Q41492800-1AAF8B63-0235-4FA0-ADBE-3BB7B77B2B4EQ42185376-5D197703-D0D9-47D8-A132-9D79A94071E3Q42539139-345191DC-68F8-42D1-B709-B43DEA2B46C6Q43441050-C5A912C0-D49F-4E20-8BA1-8EFD3FBFB867Q44778120-63EDE4CD-2DE6-4321-85BC-F53318D543A2Q45216748-774647C1-3045-47CE-9E40-F5EC986C0B3FQ45254652-DE6487F6-69FA-41D2-8F07-6EF69B3B3441Q46092553-11A9DA6B-D7DE-4B8D-B765-76FAD8B23090Q47926581-17BCBDF1-160E-4742-9B5B-8E580C653A63Q48404937-F0D943D2-1C08-4E62-A170-C0676EDF2DBBQ48420396-8014865D-1FF1-4F6A-8BBD-595276C12741Q48852162-832F4703-07AB-4993-A209-FE966B5A75ADQ49721453-E52EA2B0-F942-48DA-96D5-9CECBB41BC73Q50439837-14D031BD-BA49-4DC1-A041-72CCE1275EA9Q51053111-9D200BF6-395F-4600-9F9A-2CA3D8EE3ED5Q57253280-33A46A3D-80AA-40F3-8107-92F60D804DA0Q57780651-C901901E-C189-4D05-B398-FF5363E3EAAA
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Persistence of haloperidol in human brain tissue.
@ast
Persistence of haloperidol in human brain tissue.
@en
type
label
Persistence of haloperidol in human brain tissue.
@ast
Persistence of haloperidol in human brain tissue.
@en
prefLabel
Persistence of haloperidol in human brain tissue.
@ast
Persistence of haloperidol in human brain tissue.
@en
P2093
P356
P1476
Persistence of haloperidol in human brain tissue.
@en
P2093
Gleiter CH
Leblhuber F
Riederer P
Wiltfang J
Zöchling R
P304
P356
10.1176/AJP.156.6.885
P407
P577
1999-06-01T00:00:00Z